Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
McKinsey
Mallinckrodt
Covington
Cerilliant
Colorcon
Johnson and Johnson
Citi
Teva

Generated: June 20, 2018

DrugPatentWatch Database Preview

Codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride and what is the scope of codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride freedom to operate?

Codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride
is the generic ingredient in four branded drugs marketed by Glaxosmithkline, Sti Pharma Llc, Cenci, and Wockhardt, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride. One supplier is listed for this compound.
Summary for codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride
Pharmacology for codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride

US Patents and Regulatory Information for codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt TRIPROLIDINE HCL, PSEUDOEPHEDRINE HCL AND CODEINE PHOSPHATE codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride SYRUP;ORAL 088833-001 Nov 16, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cenci TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W/ CODEINE codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride SYRUP;ORAL 089018-001 Jul 23, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sti Pharma Llc TRIACIN-C codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride SYRUP;ORAL 088704-001 Mar 22, 1985 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline ACTIFED W/ CODEINE codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride SYRUP;ORAL 012575-003 Apr 4, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cerilliant
QuintilesIMS
Chinese Patent Office
Baxter
Chubb
US Army
McKinsey
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.